Komori, Mai http://orcid.org/0000-0001-8999-3456
Nogimori, Takuto http://orcid.org/0000-0002-6011-9631
Morey, Amber L. http://orcid.org/0000-0003-3401-9853
Sekida, Takashi
Ishimoto, Keiko http://orcid.org/0000-0002-9188-6702
Hassett, Matthew R.
Masuta, Yuji http://orcid.org/0000-0003-2349-6320
Ode, Hirotaka
Tamura, Tomokazu http://orcid.org/0000-0003-1395-6610
Suzuki, Rigel
Alexander, Jeff
Kido, Yasutoshi http://orcid.org/0000-0003-3615-2631
Matsuda, Kenta
Fukuhara, Takasuke http://orcid.org/0000-0001-5471-8331
Iwatani, Yasumasa http://orcid.org/0000-0001-9269-4828
Yamamoto, Takuya http://orcid.org/0000-0003-3753-1211
Smith, Jonathan F. http://orcid.org/0000-0002-8069-2128
Akahata, Wataru http://orcid.org/0000-0001-9207-6923
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627, JP21nf0101627)
Article History
Received: 26 October 2022
Accepted: 27 April 2023
First Online: 19 May 2023
Competing interests
: M.K., A.L.M., K.I. and K.M. are employees (VLP Therapeutics, Inc.); W.A. is a board member, an employee and holds stocks (VLP Therapeutics, Inc.); J.F.S. is an employee and holds stocks (VLP Therapeutics. Inc.); J.A. and M.R.H. were employees at VLP Therapeutics. T.S. is an employee (VLP Therapeutics Japan, LLC); W.A. is a management board member (VLP Therapeutics Japan, LLC); W.A. and J.F.S. are inventors on related vaccine patents (Coronavirus vaccine #17/232666 and Efficient vaccine #18/067358). The remaining authors declare no competing interest.